257 related articles for article (PubMed ID: 30107830)
21. Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers.
Lindsey NP; Horiuchi KA; Fulton C; Panella AJ; Kosoy OI; Velez JO; Krow-Lucal ER; Fischer M; Staples JE
J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30346562
[TBL] [Abstract][Full Text] [Related]
22. The response to re-emergence of yellow fever in Nigeria, 2017.
Nwachukwu WE; Yusuff H; Nwangwu U; Okon A; Ogunniyi A; Imuetinyan-Clement J; Besong M; Ayo-Ajayi P; Nikau J; Baba A; Dogunro F; Akintunde B; Oguntoye M; Kamaldeen K; Fakayode O; Oyebanji O; Emelife O; Oteri J; Aruna O; Ilori E; Ojo O; Mba N; Nguku P; Ihekweazu C
Int J Infect Dis; 2020 Mar; 92():189-196. PubMed ID: 31935537
[TBL] [Abstract][Full Text] [Related]
23. [Investigation of West Nile virus seroprevalence in Hacettepe University Hospital blood donors and confirmation of the positive results by plaque reduction neutralization test].
Ayturan S; Aydoğan S; Ergünay K; Ozcebe OI; Us D
Mikrobiyol Bul; 2011 Jan; 45(1):113-24. PubMed ID: 21341166
[TBL] [Abstract][Full Text] [Related]
24. Absence of YF-neutralizing antibodies in vulnerable populations of Brazil: A warning for epidemiological surveillance and the potential risks for future outbreaks.
Stoffella-Dutra AG; Silva de Oliveira J; Barbosa Costa G; Geessien Kroon E; Santos Abrahão J; Desiree LaBeaud A; Paiva Drumond B; Bretas de Oliveira D; de Souza Trindade G
Vaccine; 2020 Sep; 38(42):6592-6599. PubMed ID: 32788140
[TBL] [Abstract][Full Text] [Related]
25. An outbreak of yellow fever with concurrent chikungunya virus transmission in South Kordofan, Sudan, 2005.
Gould LH; Osman MS; Farnon EC; Griffith KS; Godsey MS; Karch S; Mulenda B; El Kholy A; Grandesso F; de Radiguès X; Brair ME; Briand S; El Tayeb el SM; Hayes EB; Zeller H; Perea W
Trans R Soc Trop Med Hyg; 2008 Dec; 102(12):1247-54. PubMed ID: 18502458
[TBL] [Abstract][Full Text] [Related]
26. DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.
Slon Campos JL; Poggianella M; Marchese S; Mossenta M; Rana J; Arnoldi F; Bestagno M; Burrone OR
PLoS One; 2017; 12(7):e0181734. PubMed ID: 28742857
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model.
Julander JG; Testori M; Cheminay C; Volkmann A
Front Immunol; 2018; 9():1756. PubMed ID: 30116244
[TBL] [Abstract][Full Text] [Related]
28. [Flavivirus seroepidemiology in blood donors in Mersin province, Turkey].
Tezcan S; Kızıldamar S; Ulger M; Aslan G; Tiftik N; Ozkul A; Emekdaş G; Niedrig M; Ergünay K
Mikrobiyol Bul; 2014 Oct; 48(4):606-17. PubMed ID: 25492656
[TBL] [Abstract][Full Text] [Related]
29. 17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil.
Campi-Azevedo AC; Peruhype-Magalhāes V; Coelho-Dos-Reis JG; Antonelli LR; Costa-Pereira C; Speziali E; Reis LR; Lemos JA; Ribeiro JGL; Bastos Camacho LA; de Sousa Maia ML; Barbosa de Lima SM; Simões M; de Menezes Martins R; Homma A; Cota Malaquias LC; Tauil PL; Costa Vasconcelos PF; Martins Romano AP; Domingues CM; Teixeira-Carvalho A; Martins-Filho OA;
Emerg Infect Dis; 2019 Aug; 25(8):1511-1521. PubMed ID: 31298654
[TBL] [Abstract][Full Text] [Related]
30. Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria.
Monath TP; Nasidi A
Am J Trop Med Hyg; 1993 Feb; 48(2):274-99. PubMed ID: 8447531
[TBL] [Abstract][Full Text] [Related]
31. Serological Protection 5-6 Years Post Vaccination Against Yellow Fever in African Infants Vaccinated in Routine Programmes.
Idoko OT; Domingo C; Tapia MD; Sow SO; Geldmacher C; Saathoff E; Kampmann B
Front Immunol; 2020; 11():577751. PubMed ID: 33133096
[No Abstract] [Full Text] [Related]
32. Global Risk and Elimination of Yellow Fever Epidemics.
Ndeffo-Mbah ML; Pandey A
J Infect Dis; 2020 Jun; 221(12):2026-2034. PubMed ID: 31545372
[TBL] [Abstract][Full Text] [Related]
33. MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination.
Vázquez S; Valdés O; Pupo M; Delgado I; Alvarez M; Pelegrino JL; Guzmán MG
J Virol Methods; 2003 Jun; 110(2):179-84. PubMed ID: 12798246
[TBL] [Abstract][Full Text] [Related]
34. Household-based sero-epidemiologic survey after a yellow fever epidemic, Sudan, 2005.
Farnon EC; Gould LH; Griffith KS; Osman MS; Kholy AE; Brair ME; Panella AJ; Kosoy O; Laven JJ; Godsey MS; Perea W; Hayes EB
Am J Trop Med Hyg; 2010 Jun; 82(6):1146-52. PubMed ID: 20519615
[TBL] [Abstract][Full Text] [Related]
35. Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay.
Adungo F; Yu F; Kamau D; Inoue S; Hayasaka D; Posadas-Herrera G; Sang R; Mwau M; Morita K
Clin Vaccine Immunol; 2016 Aug; 23(8):689-97. PubMed ID: 27307452
[TBL] [Abstract][Full Text] [Related]
36. Limitations of the complement-fixation test for distinguishing naturally acquired from vaccine-induced yellow fever infection in flavivirus-hyperendemic areas.
Monath TP; Craven RB; Muth DJ; Trautt CJ; Calisher CH; Fitzgerald SA
Am J Trop Med Hyg; 1980 Jul; 29(4):624-34. PubMed ID: 7406113
[TBL] [Abstract][Full Text] [Related]
37. Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination.
Gibney KB; Edupuganti S; Panella AJ; Kosoy OI; Delorey MJ; Lanciotti RS; Mulligan MJ; Fischer M; Staples JE
Am J Trop Med Hyg; 2012 Dec; 87(6):1112-5. PubMed ID: 23109371
[TBL] [Abstract][Full Text] [Related]
38. Recent sylvatic yellow fever virus transmission in Brazil: the news from an old disease.
Silva NIO; Sacchetto L; de Rezende IM; Trindade GS; LaBeaud AD; de Thoisy B; Drumond BP
Virol J; 2020 Jan; 17(1):9. PubMed ID: 31973727
[TBL] [Abstract][Full Text] [Related]
39. Flavivirus-induced antibody cross-reactivity.
Mansfield KL; Horton DL; Johnson N; Li L; Barrett ADT; Smith DJ; Galbraith SE; Solomon T; Fooks AR
J Gen Virol; 2011 Dec; 92(Pt 12):2821-2829. PubMed ID: 21900425
[TBL] [Abstract][Full Text] [Related]
40. Plant-Produced Subunit Vaccine Candidates against Yellow Fever Induce Virus Neutralizing Antibodies and Confer Protection against Viral Challenge in Animal Models.
Tottey S; Shoji Y; Jones RM; Chichester JA; Green BJ; Musiychuk K; Si H; Manceva SD; Rhee A; Shamloul M; Norikane J; Guimarães RC; Caride E; Silva ANMR; Simões M; Neves PCC; Marchevsky R; Freire MS; Streatfield SJ; Yusibov V
Am J Trop Med Hyg; 2018 Feb; 98(2):420-431. PubMed ID: 29231157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
